Liver Elastography in Sydney

The Liver Health Challenge in Sydney

With a population of 5.3 million and MAFLD prevalence estimated at 25-30%,Sydney clinicians face growing demand for accessible liver fibrosis assessment.

• 1
  Long specialist wait times across Western Sydney and regional NSW
• 2
  High prevalence of MAFLD in multicultural communities
• 3
  Limited access to FibroScan outside major hospital networks
• 4
  Growing diabetic population requiring regular liver monitoring
• 5
  Distance barriers for patients in Greater Western Sydney

How GLP-1 Australia Helps

• Enable point-of-care screening in GP practices across all Sydney regions
• Reduce unnecessary specialist referrals with immediate risk stratification
• 2D guidance ensures accuracy across diverse patient body types
• Generate new MBS-billable revenue stream for your practice
• Improve patient outcomes with earlier detection and intervention